BIOLINE RX LIMITED
BLRX·09071M304·US·ADR·Healthcare - Biotechnology-13D/G
BLRX (BIOLINE RX LIMITED) is held by 11 institutional investors as of Q2 2026. Largest holders: SUSQUEHANNA INTERNATIONAL GROUP, LLP ($95,824), RENAISSANCE TECHNOLOGIES LLC ($48,085), CITADEL ADVISORS LLC ($45,868). Net institutional sentiment: Mixed.
11
Holders
$205,907
Total Value
42% (12)
Consensus
5 buying - 7 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2025 · Congress none
ActivistHIHighbridge Capital Management, LLC7.2%Aug 14, 2025
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer